Clay Siegall & The Future of Cancer Research

Cancer Research is one of life’s greatest achievements thanks to it’s relevance in today’s society. Cancer has been around for decades and decades with little to no major success of eradicating the illness. Luckily in today’s time there is one organization who is revolutionizing the industry with it’s antibody breakthrough therapies. Seattle Genetics is the name and saving lives is the game. This Bothell, Washington based company is among the leaders when it comes to cancer research, development of drugs, and commercialization. Of course any great company/business needs great leadership and Clay Siegall epitomizes the word great with his very own actions.

 

Dr. Clay Siegall has been in the industry for years and has worked with some of the most high profile organizations in the field such as Bristol Myers Squibb, The National Institute of Health, and The National Cancer Institute. Dr. Siegall has built a solid structure for Seattle Genetics to stand on. His strong belief of scientific innovation, drug development, and thorough research is like the “Holy Grail” of the industry. HeraldNet News reported that in the next few years this organization will undergo some big changes as it will offering a suite of new products as well as adding another 200 employees to their roster which will bring their full total up to 1,100. Forbes has ranked Seattle Genetics as one of the fastest growing companies in America for the second year in a row.

 

All of these advancements and upgrades are courteously coming from the work of Dr. Siegall as he has been transcending the game into new territories. This accomplished individual has a resume of success including a Ph.D in Genetics, (BS) in Zoology, author of more than 70 successful publications, and currently holds about 15 patents. The greatness here just can’t be denied as the future of cancer research is in pretty good hands as long as Dr. Clay Siegall is involved in it’s daily changes.